Retraction Note: Expression of miR-1294 is downregulated and predicts a poor prognosis in gastric cancer.
The article "Expression of miR-1294 is downregulated and predicts a poor prognosis in gastric cancer" by Y.-X.
APA
Shi YX, Ye BL, et al. (2026). Retraction Note: Expression of miR-1294 is downregulated and predicts a poor prognosis in gastric cancer.. European review for medical and pharmacological sciences, 30(3), 94. https://doi.org/10.26355/eurrev_202603_37717
MLA
Shi YX, et al.. "Retraction Note: Expression of miR-1294 is downregulated and predicts a poor prognosis in gastric cancer.." European review for medical and pharmacological sciences, vol. 30, no. 3, 2026, pp. 94.
PMID
41925356
Abstract
The article "Expression of miR-1294 is downregulated and predicts a poor prognosis in gastric cancer" by Y.-X. Shi, B.-L. Ye, B.-R. Hu, X.-J. Ruan, published in Eur Rev Med Pharmacol Sci 2018; 22 (17): 5525-5530-DOI: 10.26355/eurrev_201809_15813-PMID: 30229824, has been retracted in accordance with the Publisher and the Editor in Chief. Following a previously published Expression of Concern, the Editor-in-Chief and the Publisher have completed an investigation into the issues raised in relation to this article. The investigation confirmed concerns regarding non-verifiable nucleotide sequence reagents and the use of inadequately authenticated cell lines, which undermine the reliability of the findings reported. The authors did not respond to correspondence regarding these concerns. The Editor-in-Chief and the Publisher have therefore decided to retract this article. This article has been retracted. The Publisher apologizes for any inconvenience this may cause.
같은 제1저자의 인용 많은 논문 (3)
- Multi-omics analysis identified SPRR2D as a potential biomarker for tumor prognosis and immune microenvironment infiltration: a pan-cancer perspective.
- Exploring the molecular function of LYPD3 from pan-cancer to lung cancer: based on bioinformatics and cellular experiments.
- Identify novel molecular subtypes of lung adenocarcinoma to predict treatment response and prognosis.